Praxis Precision Medicine (NASDAQ: PRAX)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Praxis Precision Medicine (NASDAQ: PRAX) through any online brokerage.
There are no as such competitors for Praxis Precision Medicine.
The latest price target for Praxis Precision Medicine (NASDAQ: PRAX) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting PRAX to fall to within 12 months (a possible -8.47% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Praxis Precision Medicine (NASDAQ: PRAX) is $4.37 last updated August 12, 2022, 8:00 PM UTC.
The next Praxis Precision Medicine (PRAX) dividend date is projected to be Thursday, September 1, 2022.
Praxis Precision Medicine’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Praxis Precision Medicine.
Praxis Precision Medicine is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.